Treatment of Inflammatory Skin Conditions
Introduction to Treatment Options
- The American Academy of Dermatology recommends treating inflammatory skin conditions, such as eczema and dermatitis, with topical corticosteroids, with concentrations of 3.3-10 mg/mL for inflammatory follicular lesions 1
- Intralesional injection of triamcinolone is effective for inflammatory nodular acne, flattening most acne nodules within 48-72 hours 1
- Topical triamcinolone acetonide 0.1% cream can be applied to affected areas, with consideration of intralesional triamcinolone for persistent individual lesions, as recommended by the American Academy of Dermatology 2, 3
Special Considerations for Topical Corticosteroid Use
- For inverse psoriasis, the American Academy of Dermatology suggests using topical corticosteroids with caution, due to increased risk of atrophy and irritation 4
- Lower potencies of topical corticosteroids or dilution with moisturizer is recommended for use in flexural areas, where penetration of medications is facilitated by local humidity 4
- Gentle cleansing and care of blisters is recommended, including antimicrobial solution, sterile needle drainage, and non-adherent dressings, with documentation of new blisters on a daily blister chart 5
- Daily washing with an antibacterial product and aseptic dressing changes can help decrease colonization, with consideration of pain management before blister care procedures 5
Treatment Duration and Frequency
- Total treatment duration can be 4-12 weeks, depending on response, with a typical reduction in frequency after clinical improvement, such as reducing frequency to once daily for 1 week, then every other day for 1 week, and finally twice weekly until discontinuation, with careful physician supervision for long-term use beyond 4 weeks 6, 3
Adverse Effects and Monitoring
- Common local adverse effects of topical corticosteroids include skin atrophy, striae, folliculitis, telangiectasia, and purpura, with high-risk areas such as the face, intertriginous areas, and chronically treated areas at greatest risk 3
- The American Academy of Dermatology recommends monitoring for development of potential adverse effects, particularly skin atrophy, striae, and folliculitis, especially in high-risk areas, and considering a steroid-sparing approach for prolonged therapy to avoid adverse effects 3
- Gradual reduction in frequency of use is recommended after clinical improvement to prevent rebound effects, with careful physician supervision for long-term use beyond 4 weeks 3
Specific Treatment Recommendations
- The American Academy of Dermatology recommends applying topical triamcinolone acetonide cream 0.1% to non-facial, non-intertriginous areas for up to 4 weeks, and using lower potency preparations or limiting duration for facial and intertriginous areas due to increased risk of skin atrophy 3
- Class 1-5 topical corticosteroids, including triamcinolone, can be used for up to 4 weeks for plaque psoriasis not involving intertriginous areas, and class 1-7 topical corticosteroids can be used for scalp psoriasis as initial and maintenance treatment 3
- In case of infection, discontinue occlusive dressings, obtain bacterial and viral swabs, and institute appropriate antimicrobial therapy, considering specialized dressings to reduce bacterial superinfection and pain 5